Component: (Network and Table)
Network
00500 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(http://www.tenethealth.com/role/StatementCondensedConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000070318 (http://www.sec.gov/CIK)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
 
Net income
176,000,000  
78,000,000  
76,000,000  
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
850,000,000  
797,000,000  
849,000,000  
Provision for doubtful accounts
1,449,000,000  
1,477,000,000  
1,305,000,000  
Deferred income tax expense
41,000,000  
42,000,000  
30,000,000  
Stock-based compensation expense
68,000,000  
69,000,000  
51,000,000  
Impairment and restructuring charges, and acquisition-related costs
202,000,000  
318,000,000  
153,000,000  
Litigation and investigation (costs) benefit
293,000,000  
291,000,000  
25,000,000  
Loss from early extinguishment of debt
 
1,000,000  
24,000,000  
Gains on sales, consolidation and deconsolidation of facilities
(151,000,000) 
(186,000,000) 
 
Equity in earnings of unconsolidated affiliates, net of distributions received
(13,000,000) 
(99,000,000) 
(10,000,000) 
Amortization of debt discount and debt issuance costs
41,000,000  
41,000,000  
28,000,000  
Pre-tax (income) loss from discontinued operations
6,000,000  
(3,000,000) 
35,000,000  
Other items, net
(1,000,000) 
59,000,000  
(30,000,000) 
Changes in cash from operating assets and liabilities:
 
 
 
Accounts receivable
(1,604,000,000) 
(1,632,000,000) 
(1,896,000,000) 
Inventories and other current assets
(83,000,000) 
(130,000,000) 
(314,000,000) 
Income taxes
(8,000,000) 
18,000,000  
3,000,000  
Accounts payable, accrued expenses and other current liabilities
(51,000,000) 
68,000,000  
505,000,000  
Other long-term liabilities
40,000,000  
38,000,000  
44,000,000  
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements
(691,000,000) 
(200,000,000) 
(168,000,000) 
Net cash used in operating activities from discontinued operations, excluding income taxes
(6,000,000) 
(21,000,000) 
(23,000,000) 
Net cash provided by operating activities
558,000,000  
 
1,026,000,000  
 
687,000,000  
 
Cash flows from investing activities:
 
 
 
Purchases of property and equipment - continuing operations
(875,000,000) 
(842,000,000) 
(933,000,000) 
Purchases of businesses or joint venture interests, net of cash acquired
(117,000,000) 
(940,000,000) 
(428,000,000) 
Proceeds from sales of facilities and other assets
573,000,000  
549,000,000  
6,000,000  
Proceeds from sales of marketable securities, long-term investments and other assets
62,000,000  
60,000,000  
52,000,000  
Purchases of equity investments
(39,000,000) 
(134,000,000) 
(12,000,000) 
Other assets
(31,000,000) 
(4,000,000) 
(8,000,000) 
Other items, net
(3,000,000) 
(6,000,000) 
1,000,000  
Net cash used in investing activities
(430,000,000) 
 
(1,317,000,000) 
 
(1,322,000,000) 
 
Cash flows from financing activities:
 
 
 
Repayments of borrowings under credit facility
(1,895,000,000) 
(2,815,000,000) 
(2,430,000,000) 
Proceeds from borrowings under credit facility
1,895,000,000  
2,595,000,000  
2,245,000,000  
Repayments of other borrowings
(154,000,000) 
(2,049,000,000) 
(683,000,000) 
Proceeds from other borrowings
760,000,000  
3,158,000,000  
1,608,000,000  
Repurchases of common stock
 
(40,000,000) 
 
Debt issuance costs
(12,000,000) 
(80,000,000) 
(27,000,000) 
Distributions paid to noncontrolling interests
(218,000,000) 
(110,000,000) 
(45,000,000) 
Proceeds from sale of noncontrolling interests
22,000,000  
11,000,000  
 
Purchase of noncontrolling interest
(186,000,000) 
(268,000,000) 
 
Proceeds from exercise of stock options
4,000,000  
15,000,000  
26,000,000  
Other items, net
16,000,000  
37,000,000  
21,000,000  
Net cash provided by financing activities
232,000,000  
 
454,000,000  
 
715,000,000  
 
Net increase in cash and cash equivalents
360,000,000  
 
163,000,000  
 
80,000,000  
 
Cash and cash equivalents at beginning of period
356,000,000  
193,000,000  
113,000,000  
Cash and cash equivalents at end of period
716,000,000  
 
356,000,000  
 
193,000,000  
 
Supplemental disclosures:
 
 
 
Interest paid, net of capitalized interest
(932,000,000) 
(859,000,000) 
(726,000,000) 
Income tax payments, net
(33,000,000) 
(7,000,000) 
(8,000,000)